Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003630:Daunorubicin / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D017290:Menogaril; D008875:Middle Aged; D009621:Nogalamycin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D012004:Rectal Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D017290:Menogaril; D009621:Nogalamycin; D003630:Daunorubicin